Rapid Response: Parkinson's & Related Diseases

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments.

Seed funding for novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Preliminary data is not required.  

Applications in this round must relate to one of the following disease(s): PD, PSP, DLB, MSA, prodromes and/or vascular contributions to these diseases.

Project Eligibility: Project must involve the development of either a therapeutic, a tool, select complementary approaches, or a combination of above to help accelerate the development of therapeutics for neurodegenerative diseases of aging.

NEW for 2018/2019:
Certain complementary approaches (i.e., diet, physical activity, sleep and nutritional supplements) will be eligible for funding through the Rapid Response program, if applications meet our disease and project scope criteria.

We encourage applications that bring in expertise, technologies or approaches in the following areas to advance the development of therapeutics and tools for neurodegenerative diseases of aging: artificial intelligence, big data, machine learning, data science, computer science, medicinal chemistry, biostatistics and engineering. Read more.

Please see the Request for Applications or visit the WBI website for more information.

Important Dates:

Parkinson’s & Related Diseases:
Program opens: May 4, 2018
Webinar June 14, 2018 at 1pm  Register here
LOI deadline: August 1, 2018 at 2:00pm EDT
Proposal deadline: November 12, 2018 at 2:00pm EST
Anticipated award notification: January 24, 2019
Agency Name: 
Weston Brain Institute
Contact Name: 
Penny D'Agnone
Grant Amount: 
Funding Available: Up to $200,000 over up to 18 months.
Grant Location: 
External Deadline: 
Wednesday, August 1, 2018
Grant Type: 
Grant Area: 
Grant Eligibility: